Acurx Pharmaceuticals Inc.

ACXP | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.33

-$0.06 (-4.32%)

At close: Sep 21, 2026, 4:00 PM ET

$1.31

-$0.02 (-1.50%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-4.32%

(1D)

Rating

Updated: Aug 22, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $5.72M

1D Range

1.32 1.41

52W Range

1.31 8.34

Valuation (TTM)

PE -0.37

PB 0.70

EV/EBITDA 0.65

Valuation (NTM)

Forward PE N/A

Forward PEG 0.03

Price Target $31

Cash Flow

FCF Yield -29993.5%

SBC Adj. FCF Yield -33514.3%

SBC Impact -11.7%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y 78.7% | 33.9%

FCF 3Y | 5Y -147.2% | -97.5%

Returns

ROA -68.3%

ROE -124.7%

ROIC -94.1%

Financial Health

Net Cash

$10.66M

Current Ratio 3.88

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Acurx Pharmaceuticals, Inc. functions as a clinical-stage biopharmaceutical firm focused on developing innovative antibiotic treatments for bacterial infections. The company's primary drug candidate i...

Sector Healthcare

Industry Biotechnology

Employees 4

IPO Date Jun 24, 2021

Website www.acurxpharma.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$31

Upside

+2230.83%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞